Skip to main content

Year: 2022

Tempest to Present at Emerging Technologies for IO Targeting and Discovery Summit

Dara Burdette, Ph.D., Tempest Senior Director of Discovery Research, to Chair “New Approaches to Solid Tumor Targeting” Session Nicholas DeVito, M.D, Duke University School of Medicine, to present TPST-1495 preclinical dataSOUTH SAN FRANCISCO, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics that combine both targeted and immune-mediated mechanisms, today announced that Dara Burdette, Ph.D., Senior Director of Discovery Research at Tempest, will present on the company’s TREX1 pipeline asset and will serve as chairperson for the “New Approaches to Solid Tumor Targeting” session at the Emerging Technologies for IO Targeting and Discovery Summit taking place October 13-14, 2022 in Boston, MA. TREX1 Presentation Dr. Burdette’s...

Continue reading

BIO-key PortalGuard Platform Wins 2022 “Access Management Solution of the Year”

Cybersecurity Breakthrough Awards Recognize Outstanding Information Security Products & CompaniesBIO-key PortalGuard Platform Wins 2022 “Access Management Solution of the Year” Cybersecurity Breakthrough Awards Recognize Outstanding Information Security Products & CompaniesWALL, N.J., Oct. 06, 2022 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today announced its PortalGuard® platform has been selected as the winner of the “Access Management Solution of the Year” award in the sixth annual, 2022 CyberSecurity Breakthrough Awards conducted by CyberSecurity Breakthrough, for the second consecutive year. This acknowledgement adds to a growing list of industry awards the platform has...

Continue reading

Orion Adds Electric Vehicle Charging Station Solutions Via Voltrek Acquisition

Hosts Investor Call today at 4:15pm ET to Discuss the Acquisition MANITOWOC, Wis. and BOSTON, Oct. 06, 2022 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, controls and electrical installation and maintenance services announced today its expansion into the electric vehicle (EV) charging station market through the acquisition of Voltrek, LLC. Voltrek had 2021 revenue of $4.8M primarily from projects in New England. Orion will host an investor call today at 4:15 pm ET to discuss the acquisition. Call details are below. Voltrek provides turnkey EV charging solutions and ongoing support to all commercial verticals, working as a value-added resale partner to leading Electric Vehicle Supply Equipment and Electric Vehicle Service Providers, offering turnkey solutions...

Continue reading

Biochar Market Size Worth USD 365 Million, Globally, by 2028 at 12.1% CAGR

According to Fortune Business Insights, the global Biochar market size is projected to grow from USD 149.2 Million in 2020 to USD 365 Million in 2028, at CAGR of 12.1% during forecast period; Pune, India, Oct. 06, 2022 (GLOBE NEWSWIRE) — The global Biochar Market was USD 149.2 Million in 2020. The global market size is expected to be grow from USD 164.5 million in 2021 and is projected to reach USD 365.0 million by 2028, exhibiting a CAGR of 12.1% during the forecast period from 2021-2028. This information is provided by Fortune Business Insights, in its report, titled, “Biochar Market, 2021-2028.” According to our analysts, the factors such as growing government policies for environmental protection and growing utilization of biochar for livestock feed to propel market growth amplified market growth.Request a Sample Copy of...

Continue reading

Costamare Inc. Announces Election of Class III Directors at 2022 Annual Meeting of Stockholders

MONACO, Oct. 06, 2022 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company”) (NYSE: CMRE), an international owner and provider of containerships and dry bulk vessels for charter, announced the election of two Class III directors at the Company’s annual meeting of stockholders held in Monaco today. The elected Class III directors are Konstantinos Konstantakopoulos and Charlotte Stratos. Each Class III director was elected to hold office for a term ending at the annual meeting of stockholders in 2025 and until his or her successor has been duly elected and qualified. Stockholders also ratified the appointment of Ernst & Young (Hellas) Certified Auditors Accountants S.A. as the Company’s independent auditors for the fiscal year ending December 31, 2022. About Costamare Inc. Costamare Inc. is one of the world’s leading owners...

Continue reading

Advanced Energy Storage System Market Size Worth USD 211 Billion, Globally, by 2026 at 4.82% CAGR

According to Fortune Business Insights, the global Advanced Energy Storage System market size is projected to grow from USD 145 billion in 2018 to USD 211 billion in 2026, at CAGR of 4.82% during forecast period; Pune, India, Oct. 06, 2022 (GLOBE NEWSWIRE) — The global Advanced Energy Storage System Market was USD 145 billion in 2018. The global market size is expected to be reach USD 211 billion by 2026, exhibiting a CAGR of 4.82% during the forecast period from 2021-2026. This information is provided by Fortune Business Insights, in its report, titled, “Advanced Energy Storage System Market, 2021-2026.” According to our analysts, the factors such as increasing number of solar farms and growing awareness of energy conservation will favor growth. Recent advancements in advanced energy storage industry have, therefore, favored...

Continue reading

Landec Corporation Reports First Quarter Fiscal Year 2023 Results

Lifecore segment revenues increased 8.0% to $23.7 million in fiscal 2023 first quarter versus the prior year periodLifecore segment EBITDA increased 8.1% to $2.5 million in fiscal 2023 first quarter versus the prior year periodReiterates fiscal 2023 full year guidance for LifecoreCorporate rebranding to Lifecore Biomedical continues to progress SANTA MARIA, Calif. and MINNEAPOLIS, Oct. 06, 2022 (GLOBE NEWSWIRE) — Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. (“Lifecore”) and Curation Foods, Inc. (“Curation Foods”), reported results for the fiscal 2023 first quarter ended August 28, 2022. With the sale of BreatheWay early in the fiscal first quarter 2023, combined with the prior dispositions of Eat Smart and Windset,...

Continue reading

Akoustis Becomes Charter Member of the Semiconductor Industry Association

The SIA Advances Policies to Help Grow the Semiconductor Industry and Fuel Innovation, Propel Business and Drive International Competition Akoustis Exemplifies US-Based Semiconductor Innovation with Its Disruptive XBAW TechnologyCharlotte, N.C., Oct. 06, 2022 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced that it has joined the Semiconductor Industry Association (SIA) as a Charter Member, alongside industry stalwarts including Intel, Micron, Qualcomm, AMD and others. Since 1977, the Semiconductor Industry Association (SIA) has been the voice of the U.S. semiconductor industry, one of America’s top export industries, and a key driver...

Continue reading

Sandy Spring Bancorp, Inc. to Webcast Third Quarter Earnings Conference Call on October 20, 2022

OLNEY, Md., Oct. 06, 2022 (GLOBE NEWSWIRE) — Sandy Spring Bancorp, Inc. (Nasdaq: SASR) will announce its third quarter earnings on Thursday, October 20, 2022. The company will hold a conference call that day at 2:00 p.m. (ET) to discuss results and answer questions. The conference call will be webcast live through the Sandy Spring Bank website.  Those who wish to participate in order to ask questions may do so by calling 1- 844-200-6205; please use Access Code: 142064. Those who wish to listen to the call should go to the Investor Relations page of www.sandyspringbank.com and log on 10 minutes ahead of the scheduled start of the call. An internet-based replay will be available on the Investor Relations page of the website until November 3, 2022. A telephone voice replay will also be available during that same time period at 1-866-813-9403....

Continue reading

AN2 Therapeutics Provides Update on Epetraborole Ex-U.S. Development Plan in Treatment-Refractory MAC Lung Disease

Epetraborole Data from Recently Completed Phase 1 Study in Japanese Subjects Supports Use of Once Daily, 500 mg Dose in Japanese Patients Treatment-Refractory MAC Lung Disease Clinical Development Strategy to Focus Initially on Japan and U.S., Two Countries with Highest Prevalence of MAC Lung Disease Epetraborole Granted Orphan Medicinal Product Designation in NTM Lung Disease in European UnionMENLO PARK, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) — AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today provided an update on the ex-U.S. development plan for epetraborole in treatment-refractory Mycobacterium avium complex (MAC) lung disease, the most common form of non-tuberculous mycobacterial...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.